Condition
Undifferentiated Connective Tissue Disease
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT02234388RecruitingPrimary
Undifferentiated Connective Tissue Disease Registry
NCT02298777Terminated
Metabolomic Analysis of Systemic Sclerosis
NCT03840928Unknown
PatientSpot Formerly Known as ArthritisPower
NCT03671174Not ApplicableUnknownPrimary
Immunosuppressant Regimens for Living Fetuses Study
Showing all 4 trials